Sage Journals: Discover world-class research

Abstract

Carrageenan is a thermoreversible polymer of natural origin widely used in food and pharmaceutical industry that presents a glycosaminoglycan-like structure. Herein, we show that kappa-type carrageenan extracted by a semi-refined process from the red seaweed Kappaphycus alvarezii displayed both chemical and structural properties similar to a commercial carrageenan. Moreover, both extracted carrageenan hydrogel and commercial carrageenan hydrogel can serve as a scaffold for in vitro culture of human skin-derived multipotent stromal cells, demonstrating considerable potential as cell-carrier materials for cell delivery in tissue engineering. Skin-derived multipotent stromal cells cultured inside the carrageenan hydrogels showed a round shape morphology and maintained their growth and viability for at least one week in culture. Next, the effect of the extracted carrageenan hydrogel loaded with human skin-derived multipotent stromal cells was evaluated in a mouse model of full-thickness skin wound. Macroscopic and histological analyses revealed some pointed ameliorated features, such as reduced inflammatory process, faster initial recovery of wounded area, and improved extracellular matrix deposition. These results indicate that extracted carrageenan hydrogel can serve as a scaffold for in vitro growth and maintenance of human SD-MSCs, being also able to act as a delivery system of cells to wounded skin. Thus, evaluation of the properties discussed in this study contribute to a further understanding and specificities of the potential use of carrageenan hydrogel as a delivery system for several applications, further to skin wound healing.

Keywords

Multipotent stromal cells carrageenan hydrogel scaffold skin wound healing tissue engineering

Get full access to this article

View all access options for this article.

References

Apelqvist

Willy

Fagerdahl

A-M

et al . EWMA document: negative pressure wound therapy. J Wound Care 2017; 26: S1–S154.

Samsonraj

Raghunath

Nurcombe

et al . Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med 2017; 6: 2173–2185.

Dominici

Le Blanc

Mueller

et al . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–317.

Jeremias

TDS

Machado

Visoni

SBC

et al . Dermal substitutes support the growth of human skin-derived mesenchymal stromal cells: potential tool for skin regeneration. PLoS One 2014; 9: e89542.

Falanga

Iwamoto

Chartier

et al . Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007; 13: 1299–1312.

Griffith

Swartz

MA.

Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006; 7: 211–224.

Kim

Baez

Atala

Biomaterials for tissue engineering. Ann Biomed Eng 2000; 2–9.

Junmin Zhu

REM.

Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices 2011; 8: 607–626.

Trono

GC.

Eucheuma and Kappaphycus : taxonomy and cultivation. Bull Mar Sci 1992; 51–65.

10.

Mano

Silva

Azevedo

et al . Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 2007; 4: 999–1030.

11.

van de Velde

Knutsen

Usov

et al . 1H and 13C high resolution NMR spectroscopy of carrageenans: application in research and industry. Trends Food Sci Technol 2002; 13: 73–92.

12.

Campo

Kawano

Silva

DBD

et al . Carrageenans: biological properties, chemical modifications and structural analysis – a review. Carbohydr Polym. 2009; 77: 167–180.

13.

Bonferoni

Chetoni

Giunchedi

et al . Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies. Eur J Pharm Biopharm 2004; 57: 465–472.

14.

Hosseinzadeh

Controlled release of diclofenac sodium from pH-responsive carrageenan-g-poly(acrylic acid) superabsorbent hydrogel. J Chem Sci 2011; 122: 651–659.

15.

Grenha

Gomes

Rodrigues

et al . Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res A 2010; 92: 1265–1272.

16.

Santo

Frias

Carida

et al . Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009; 10: 1392–1401.

17.

Desai

Dave

Devi

Entrapment of lipase into K-carrageenan beads and its use in hydrolysis of olive oil in biphasic system. J Mol Catal B Enzym 2004; 31: 143–150.

18.

Rocha

Santo

Gomes

et al . Encapsulation of adipose-derived stem cells and transforming growth factor-1 in carrageenan-based hydrogels for cartilage tissue engineering. J Bioact Compat Polym 2011; 26: 493–507.

19.

da Cunha

de Oliveira

Maia

et al . Pharmaceutical grade chondroitin sulfate: structural analysis and identification of contaminants in different commercial preparations. Carbohydr Polym 2015; 134: 300–308.

20.

Dodgson

KS.

Determination of inorganic sulphate in studies on the enzymic and non-enzymic hydrolysis of carbohydrate and other sulphate esters. Biochem J 1961; 78: 312–319.

21.

Wang

Tredget

et al . The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc 2013; 8: 302–309.

22.

Coffman

Parsonage

D’Agostino

et al . Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci USA 2009; 106: 570–575.

23.

Mihaila

Popa

Reis

et al . Fabrication of endothelial cell-laden carrageenan microfibers for microvascularized bone tissue engineering applications. Biomacromolecules 2014; 15: 2849–2860.

24.

Mihaila

Gaharwar

Reis

et al . Photocrosslinkable kappa-carrageenan hydrogels for tissue engineering applications. Adv Healthc Mater 2012; 1–13.

25.

Abaee

Mohammadian

Jafari

SM.

Whey and soy protein-based hydrogels and nano-hydrogels as bioactive delivery systems. Trends Food Sci Technol 2017; 70: 69–81.

26.

Mokhtari

Jafari

Assadpour

Development of a nutraceutical nano-delivery system through emulsification/internal gelation of alginate. Food Chem 2017; 229: 286–295.

27.

Hayashi

Santos

Faria

GSM

et al . Kappaphycus alvarezii (Rhodophyta, Areschougiaceae) cultivated in subtropical waters in Southern Brazil. J Appl Phycol 2011; 23: 337–343.

28.

De Ruiter

Rudolph

Carrageenan biotechnology. Trends Food Sci Technol 1997; 8: 389–395.

29.

Lim

Gwon

Choi

et al . Preparation and biocompatibility study of gelatin/kappa-carrageenan scaffolds. Macromol Res 2010; 18: 29–34.

30.

Popa

Carvalho

Dias

et al . Evaluation of the in vitro and in vivo biocompatibility of carrageenan-based hydrogels. J Biomed Mater Res A 2014; 2009: 1–11.

31.

Opoku

Qiu

Doctor

Effect of oversulfation on the chemical and biological properties of kappa carrageenan. Carbohydr Polym 2006; 65: 134–138.

32.

Silva

FRF

Dore

CMPG

Marques

et al . Anticoagulant activity, paw edema and pleurisy induced carrageenan: action of major types of commercial carrageenans. Carbohydr Polym 2010; 79: 26–33.

33.

Nicodemus

Bryant

SJ.

Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 2008; 14: 149–165.

34.

Popa

Gomes

Reis

RL.

Cell delivery systems using alginate–carrageenan hydrogel beads and fibers for regenerative medicine applications. Biomacromolecules 2011; 12: 3952–3961.

35.

Popa

Reis

Gomes

Chondrogenic phenotype of different cells encapsulated in κ-carrageenan hydrogels for cartilage regeneration strategies. Biotechnol Appl Biochem 2012; 59: 132–141.

36.

Thakur

Jaiswal

Peak

et al . Injectable shear-thinning nanoengineered hydrogels for stem cell delivery. Nanoscale 2016; 8: 12362–12372.

37.

Hashemi Tabatabaei

Jafari

Mirzaei

et al . Preparation and characterization of nano-SiO₂ reinforced gelatin-k-carrageenan biocomposites. Int J Biol Macromol 2018; 111: 1091–1099.

38.

Lee

Pulin

Seo

et al . Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54–63.

39.

Toma

Wagner

Bowry

et al . Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res 2009; 104: 398–402.

40.

Chen

Tredget

Liu

et al . Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One. 2009; 4: e7119 .

41.

Nauta

Fibbe

WE.

Immunomodulatory properties of mesenchymal stromal cells. Blood 2008; 110: 3499–3506.

42.

Baraniak

McDevitt

TC.

Stem cell paracrine actions and tissue regeneration. Regen Med 2010; 5: 121–143.

43.

Aggarwal

Pittenger

MF.

Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822.

44.

Beyth

Borovsky

Mevorach

et al . Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105: 2214–2219.

45.

Singer

Caplan

AI.

Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol Mech Dis 2011; 6: 457–478.

46.

Yao

Zhang

et al . Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity. Carbohydr Polym 2014; 101: 359–367.

47.

Pankajakshan

Agrawal

DK.

Mesenchymal stem cell paracrine factors in vascular repair and regeneration. J Biomed Technol Res 2014; 1: 21.

48.

Zhang

et al . Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 2009; 36: 725–731.

49.

Suga

Eto

Shigeura

et al . IFATS collection: fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells 2009; 27: 238–249.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.27 MB

Carrageenan hydrogel as a scaffold for skin-derived multipotent stromal cells delivery

Abstract

Keywords

Get full access to this article

References

Supplementary Material